
No patents, no new drugs
The U.S. Congress recently approved a bill to allow the re-importation of U.S.-made prescription drugs from Europe and Canada. Though this plan may save consumers money, it will also reduce the incentives for drug companies to develop expensive but potentially life-saving new drugs, says Stephen Entin of the Institute for





